Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill M Kolesar

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 20, 2005
Bevacizumab: improved survival at what cost?Jill M Kolesar
Managed Care (Langhorne, Pa.)|December 20, 2008
Assessing therapeutically developed assaysJill M Kolesar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 9, 2002
Novel approaches to anemia associated with cancer and chemotherapyJill M Kolesar
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 17, 2011
Targeted therapy for NSCLC: ALK inhibitionRachel Pearson, Jill M Kolesar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 24, 2005
Role of adjuvant chemotherapy in the treatment of non-small-cell lung cancerLindsey Wilhelm, Jill M Kolesar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 21, 2013
Crizotinib for the treatment of non-small-cell lung cancerAndrew Timm, Jill M Kolesar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 31, 2013
Vismodegib for the treatment of basal cell skin cancerLaura Poggi, Jill M Kolesar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2013
Assays for biological agentsJill M Kolesar, Lee Vermeulen
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 4, 2013
Vemurafenib and ipilimumab: new agents for metastatic melanomaMegan Banaszynski, Jill M Kolesar
Clinical Therapeutics|November 8, 2011
Eltrombopag: an oral thrombopoietin receptor agonist for the treatment of idiopathic thrombocytopenic purpuraYang Zhang, Jill M Kolesar
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 20, 2005
Bevacizumab: improved survival at what cost?Jill M Kolesar
Managed Care (Langhorne, Pa.)|December 20, 2008
Assessing therapeutically developed assaysJill M Kolesar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 9, 2002
Novel approaches to anemia associated with cancer and chemotherapyJill M Kolesar
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 17, 2011
Targeted therapy for NSCLC: ALK inhibitionRachel Pearson, Jill M Kolesar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 24, 2005
Role of adjuvant chemotherapy in the treatment of non-small-cell lung cancerLindsey Wilhelm, Jill M Kolesar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 21, 2013
Crizotinib for the treatment of non-small-cell lung cancerAndrew Timm, Jill M Kolesar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 31, 2013
Vismodegib for the treatment of basal cell skin cancerLaura Poggi, Jill M Kolesar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2013
Assays for biological agentsJill M Kolesar, Lee Vermeulen
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 4, 2013
Vemurafenib and ipilimumab: new agents for metastatic melanomaMegan Banaszynski, Jill M Kolesar
Clinical Therapeutics|November 8, 2011
Eltrombopag: an oral thrombopoietin receptor agonist for the treatment of idiopathic thrombocytopenic purpuraYang Zhang, Jill M Kolesar
Pageof 15